Effects of glucocorticoids on endogenous and transcellular metabolism of eicosanoids in asthma

The Journal of Allergy and Clinical Immunology
I VachierPascal Chanez

Abstract

Human blood polymorphonuclear cells, which biosynthesize eicosanoids from the 5-lipoxygenase (5-LO) pathway, are likely to be involved in asthma, in which glucocorticoids represent the first line of therapy. Their effects on leukotriene release after a short course of treatment, which have been reported in several studies, are controversial. We sought to investigate whether long-term oral glucocorticoids inhibit lipid mediators from the 5-LO pathway. Twelve normal control subjects, 29 asthmatic subjects, and 50 glucocorticoid-dependent asthmatic subjects were included in the study. Polymorphonuclear cells were studied for endogenous and transcellular metabolism of eicosanoids. Total leukotriene B(4) production was significantly lower in cells from glucocorticoid-dependent asthmatic subjects (mean +/- SD, 177 +/- 26 ng/10(7) cells) than in control subjects (406 +/- 27), untreated asthmatic subjects (421 +/- 34), and asthmatic subjects treated with inhaled glucocorticoids (290 +/- 56). When incubated with arachidonic acid, these polymorphonuclear cells released very low amounts of 5(S)- and 12(S)-hydroxy-eicosatetraenoic acid (HETE), whereas endogenous 15(S)-HETE was found in substantial amounts. The transformation of exogenous 1...Continue Reading

References

May 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·P Borgeat, B Samuelsson
Apr 1, 1992·British Journal of Clinical Pharmacology·A P SampsonP J Piper
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R J SebaldtG A FitzGerald
Aug 1, 1990·Prostaglandins, Leukotrienes, and Essential Fatty Acids·N ShiratsukiS Yamamoto
Aug 1, 1989·Canadian Journal of Physiology and Pharmacology·P Borgeat
Dec 1, 1989·The American Review of Respiratory Disease·P K JefferyA B Kay
Nov 1, 1985·Prostaglandins, Leukotrienes, and Medicine·K M Robinson, J H Botha
Jan 15, 1986·The Biochemical Journal·K A HainesG Weissmann
Jan 1, 1988·Annals of the New York Academy of Sciences·J Y Vanderhoek
Feb 1, 1988·Journal of Steroid Biochemistry·D K SorensonD H Nelson
Feb 6, 1995·Biochemical and Biophysical Research Communications·C ChavisP Godard
Nov 1, 1994·Annals of Internal Medicine·W R Henderson
Sep 1, 1993·The Journal of Allergy and Clinical Immunology·D Cypcar, W W Busse
Jan 1, 1993·Annual Review of Medicine·P J Barnes
Oct 6, 1997·American Journal of Respiratory and Critical Care Medicine·S E WenzelR J Martin
May 16, 1998·The European Respiratory Journal·M MajoriP Chanez
Sep 10, 1998·American Journal of Respiratory and Critical Care Medicine·I VachierP Chanez
Jul 21, 2000·American Journal of Respiratory and Critical Care Medicine·R GagliardoM Mathieu
Aug 10, 2000·The European Respiratory Journal·M SanakA Szczeklik

❮ Previous
Next ❯

Citations

Jan 7, 2021·Therapeutic Advances in Endocrinology and Metabolism·Jan LängerichtGeorge J Kahaly
Jul 25, 2003·Pulmonary Pharmacology & Therapeutics·Gaetano Caramori, Ian Adcock

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.